A blended-style global all-cap equity fund seeking growth.
Is this fund right for you?
- A person who is investing for the longer term, seeking the growth potential of foreign stocks and is comfortable with Medium risk.
- A person who is investing for the longer term, seeking the growth potential of foreign stocks and is comfortable with Medium risk.
- Since the fund invests in stocks its value is affected by stock prices, which can rise and fall in a short period of time.
- Since the fund invests in stocks its value is affected by stock prices, which can rise and fall in a short period of time.
Risk Rating
How is the fund invested?
(as of June 30, 2023)
Asset allocation (%)
|
Name |
Percent |
|
US Equity |
46.2 |
|
International Equity |
42.4 |
|
Canadian Equity |
8.2 |
|
Cash and Equivalents |
3.2 |
Geographic allocation (%)
|
Name |
Percent |
|
United States |
46.2 |
|
Canada |
11.4 |
|
France |
5.3 |
|
Switzerland |
4.8 |
|
United Kingdom |
4.6 |
|
Denmark |
3.9 |
|
Netherlands |
3.4 |
|
India |
2.9 |
|
Japan |
2.8 |
|
Other |
14.7 |
Sector allocation (%)
|
Name |
Percent |
|
Technology |
18.9 |
|
Healthcare |
17.1 |
|
Financial Services |
12.9 |
|
Consumer Goods |
9.8 |
|
Industrial Goods |
9.7 |
|
Consumer Services |
8.6 |
|
Energy |
7.5 |
|
Industrial Services |
5.6 |
|
Basic Materials |
3.7 |
|
Other |
6.2 |
Growth of $10,000
(since inception)
Data not available based on date of inception
Fund details
(as of June 30, 2023)
Top holdings |
% |
Eli Lilly and Co |
2.9 |
Microsoft Corp |
2.8 |
Novo Nordisk A/S Cl B |
2.7 |
Taiwan Semiconductor Manufactrg Co Ltd |
2.5 |
UnitedHealth Group Inc |
2.3 |
Apple Inc |
1.9 |
Meta Platforms Inc Cl A |
1.7 |
Applied Materials Inc |
1.6 |
Thermo Fisher Scientific Inc |
1.5 |
Rockwell Automation Inc |
1.4 |
Total allocation in top holdings |
21.3 |
Portfolio characteristics |
|
Standard deviation |
14.2% |
Dividend yield |
1.4% |
Average market cap (million) |
$387,796.6 |
Understanding returns
Annual compound returns (%)
1 MO |
3 MO |
YTD |
1 YR |
{{snapShot.Return1Mth|customNumber:1}} |
{{snapShot.Return3Mth|customNumber:1}} |
{{snapShot.ReturnYTD|customNumber:1}} |
{{snapShot.Return1Yr|customNumber:1}} |
3 YR |
5 YR |
10 YR |
INCEPTION |
{{snapShot.Return3Yr|customNumber:1}} |
{{snapShot.Return5Yr|customNumber:1}} |
{{snapShot.Return10Yr|customNumber:1}} |
{{snapShot.ReturnInception|customNumber:1}} |
Calendar year returns (%)
2022 |
2021 |
2020 |
2019 |
{{snapShot.Return1YrCalendar|customNumber:1}} |
{{snapShot.Return2YrCalendar|customNumber:1}} |
{{snapShot.Return3YrCalendar|customNumber:1}} |
{{snapShot.Return4YrCalendar|customNumber:1}} |
2018 |
2017 |
2016 |
2015 |
{{snapShot.Return5YrCalendar|customNumber:1}} |
{{snapShot.Return6YrCalendar|customNumber:1}} |
{{snapShot.Return7YrCalendar|customNumber:1}} |
{{snapShot.Return8YrCalendar|customNumber:1}} |
Range of returns over five years
Best return |
Best period end date |
Worst return |
Worst period end date |
Data not available based on date of inception
|
Average return |
% of periods with positive returns |
Number of positive periods |
Number of negative periods |
Data not available based on date of inception
|